Dectomax CA-1

The USDA's Animal and Plant Health Inspection Service (APHIS) has issued a Special Notice on February 24, 2026, announcing its intention to award a sole-source supply contract to Zoetis US, LLC for a one-time purchase of Dectomax CA-1 injectable. This procurement is authorized under FAR 6.302-1, which permits sole-source acquisitions when only one responsible source can satisfy agency requirements. The contract will be conducted as a Firm-Fixed Price purchase under FAR Part 12 (Acquisition of Commercial Items). APHIS determined that Zoetis is the only manufacturer of this product, which is the sole FDA conditionally approved injectable medication for treating and preventing New World Screwworm in cattle. The agency is accepting voluntary capability information from interested sources, including small businesses, through March 23, 2026, to inform its final determination on whether to proceed with the sole-source award.

The primary objective behind this procurement is to establish a government stockpile of Dectomax CA-1 as a critical backstop for states in response to the imminent threat of New World Screwworm detection in the United States, with cases currently located within 70-200 miles of the Texas border. The product addresses an urgent animal health need given the shortage of large animal veterinarians nationally and the lack of any alternative injectable macrocytic lactone medication approved for this indication in cattle. Interested sources, particularly small businesses capable of providing the product, must submit detailed capability information by the March 23, 2026 closing date via email to Jason.L.Wilking@usda.gov; however, the government will not award a contract based on this information or reimburse participants for their submissions. No competitive proposals are being sought, and no requests for capability briefings will be honored. Pricing will be determined through comparison with historical Dectomax purchases, and the USDA indicates that future acquisitions may be sourced from small business distributors once Zoetis makes the product commercially available.